The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
Multiple sclerosis is the most common chronic demyelinating neurodegenerative central nervous system disease among young adults. Considering its extent in a relatively young population, multiple sclerosis determines a significant socioeconomic burden to the society due to the cost of disease modify...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Vilnius University Press
2024-03-01
|
| Seri Bilgileri: | Neurologijos seminarai |
| Konular: | |
| Online Erişim: | https://test.zurnalai.vu.lt/neurologijos_seminarai/article/view/34911 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|